What’s new in Pulmonary Hypertension on the Knowledge Sharing Platform in July 2026

This month’s round-up brings together a mix of clinical trial data, emerging science, and a few broader conversations about care. Beyond the data, it also touches on the human side of PH care: a look at quality of life and mental health in patients on prostacyclin therapy, and a conversation on “caring for the whole person” with nurse practitioner Susanne McDevitt. We also feature a review on disparities affecting historically marginalized populations with PAH, alongside a timely piece on the ethical application of AI in digital health.

📖 PH Field Overview

  • “Pulmonary Arterial Hypertension: How far we’ve come—and what’s next” (Circulation)

🔬 Clinical Trials & Drug Research

  • Ralinepag / ADVANCE OUTCOMES phase 3 trial (The Lancet)
  • Early parenteral prostacyclin therapy outcomes (European Respiratory Journal)
  • Phase 2 trial for PH-HFpEF completes enrolment
  • Food and Drug Administration (FDA) orphan drug status for IKT-001/imatinib (Inhibikase)

🧬 Basic Science & Disease Mechanisms

  • Activin Signaling Inhibitors review (Pulmonary Circulation/PVRI)
  • Placental growth factor (PlGF) as new pulmonary arterial hypertension driver (Cardiovascular Research)

💙 Patient Wellbeing & Quality of Life

  • Quality of Life outcomes with prostacyclin therapy — anxiety/depression factors (Turkish Cardiology Journal)
  • “Caring for the Whole Person” — Susanne McDevitt interview (HCPLive)
  • French FONCE-HTAP rehabilitation study (Annals of ATS)

⚖️ Health Equity & Disparities

  • Historically Marginalized and Minoritized Populations with pulmonary arterial hypertension (CHEST)

🤖 AI & Digital Health Ethics

  • Ethical Application of AI in Digital Health / “misrecognition” (European Heart Journal – Digital Health)
  • American Thoracic Society (ATS) 2026 conference: AI, Innovation, and Humanism in medicine

🌍 Global Access & Advocacy

  • Pulmonary Vascular Research VRI launches Global Pulmonary Hypertension Consult (free clinician case-discussion service)
  • Patient advocate Natalia Maeva at European Respiratory Society (ERS) Presidential Summit
  • EU Commission fact sheets on transborder rare disease care

📅 Events & Conferences

  • PH Update 2026 – Gateway to the 8th World Symposium (Ann Arbor, Oct 2)
  • ATS annual conference 2026 recap

🫁 Transplant

  • Transplant International May 2026 e-book (lung transplant recipient’s Aconcagua summit)

📈 Industry/Market

  • Respiratory inhaler devices market outlook through 2030
TRANSLATE »
Scroll to Top